StonvexLoading…
StonvexStonvexStonvexCore line items from CTNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $92.70K | $1.29M | $1.20M | $833.92K |
Operating Income | $-764.32K | $-4.58M | $-3.31M | $-1.74M |
Net Income | $-616.26K | $-3.65M | $-2.58M | $-1.27M |
EPS (Diluted) | $-4.53 | $-1.12 | $-0.80 | $-0.39 |
Total Assets | $51.00M | $11.86M | $12.80M | $13.90M |
Total Liabilities | $2.10M | $2.50M | $2.66M | $2.52M |
Cash & Equivalents | $713.95K | $233.22K | $153.69K | $185.19K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 184.35K | 17.10K | 3.27M | 3.22M |